LIXTE BIOTECHNOLOGY HOLDINGS (LIXT)

US5393193017 - Common Stock

3.38  -0.14 (-3.98%)

After market: 3.35 -0.03 (-0.89%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
5.69M6.31M6.72M3.27M2.49M
Research and Development
1.20M1.35M1.74M1.22M820.00K
Selling, General, and Administrative Expenses
4.49M4.96M4.98M2.04M1.67M
Operating Income
-5.69M-6.31M-6.72M-3.27M-2.49M
Interest Income/Expense
5.42K0.00-10.00K0.0050.00K
Other Income/Expense
N/AN/AN/AN/AN/A
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-5.69M-6.31M-6.73M-3.26M-2.44M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-5.69M-6.31M-6.73M-3.26M-2.44M
 
Per Share Data
EPS Diluted Total Ops
-3.29-3.99-4.99-2.90-2.18
 
Statistics
Profit Margin
N/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/A

All data in USD

Charts